High IKZF1/3 protein expression is a favorable prognostic factor for survival of relapsed/refractory multiple myeloma patients treated with lenalidomide
Crossref DOI link: https://doi.org/10.1186/s13045-016-0354-2
Published Online: 2016-11-21
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pourabdollah, Maryam
Bahmanyar, Mohammad
Atenafu, Eshetu G.
Reece, Donna
Hou, Jian
Chang, Hong
Funding for this research was provided by:
Leukemia and Lymphoma Society of Canada